Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Fiber fermentation by gut microbiota yields short-chain fatty acids (SCFAs) that are either absorbed by the gut or excreted in feces. Studies are conflicting as to whether SCFAs are beneficial or detrimental to cardiometabolic health, and how gut microbiota associated with SCFAs is unclear. In this study of 441 community-dwelling adults, we examined associations of fecal SCFAs, gut microbiota diversity and composition, gut permeability, and cardiometabolic outcomes, including obesity and hypertension. We assessed fecal microbiota by 16S rRNA gene sequencing, and SCFA concentrations by gas chromatography/mass spectrometry. Fecal SCFA concentrations were inversely associated with microbiota diversity, and 70 unique microbial taxa were differentially associated with at least one SCFA (acetate, butyrate or propionate). Higher SCFA concentrations were associated with a measure of gut permeability, markers of metabolic dysregulation, obesity and hypertension. Microbial diversity showed association with these outcomes in the opposite direction. Associations were significant after adjusting for measured confounders. In conclusion, higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, excess adiposity, and cardiometabolic risk factors. Studies assessing both fecal and circulating SCFAs are needed to test the hypothesis that the association of higher fecal SCFAs with obesity and cardiometabolic dysregulation is due to less efficient SCFA absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B., & Raoult, D. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.20 · Cited by 362
RetractedSchloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549 · cited 1×
“36 [22] following its standard operating procedure available November 2015.”
MethodAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“, homozygous for a mutation in the leptin gene (ob/ob) that produces a stereotyped, fully penetrant obesity phenotype) compared to their lean siblings (ob/+ and +/+) have a gut microbiome composition that promotes obesity through excess SCFA production and increased energy availability [14].”
BackgroundStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891 · cited 1×
“OTUs delimited at 97% identity were generated and classified using Greengenes 13_8_99 [23].”
MethodA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“, acetyl/propionyl-CoA carboxylase and acetyl-CoA carboxylase) [17].”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“LBP is a biomarker of bacterial-derived LPS translocation from the gut to the periphery and higher serum LBP levels are thought to reflect gut permeability [43] and metabolic endotoxemia [44].”
BackgroundThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413 · cited 1×
“SCFAs may also be involved in appetite regulation [9], and play a role in gut and peripheral immune responses [10]; inducing the differentiation of T-regulatory cells [11].”
BackgroundCani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 1×
“On the other hand, participants with lower fecal SCFA excretion had a diverse microbiome, enriched in beneficial microbes including Akkermansia muciniphila, a taxon involved in maintaining the integrity of the mucin layer [50]; Christensenellaceae, Methanobrevibacter and Oscillospira, taxa associated with lower BMI [5…”
Background
Research works printed but not linked: 1
- (2017, June 01). IPAQ Research Committee Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ): Short and Long Forms. Available online: http://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents.
Cited by
Items 201–300 of 556
Hereu, M., Ramos-Romero, S. O., Marín‐Valls, R., Amézqueta, S., Miralles‐Pérez, B., Romeu, M., Méndez, L., Medina, I., & Torres, J. L. (2019) · Nutrients · doi:10.3390/nu11112606 · Cited by 23
Zou, J., Qin, X., Tan, D., Shi, L., Liu, X., Wu, Y., & Yu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114002 · Cited by 23
Kwek, E., Zhu, H., Ding, H., He, Z., Hao, W., Liu, J., Ma, K. Y., & Chen, Z. (2022) · European Journal of Nutrition · doi:10.1007/s00394-021-02785-9 · Cited by 24
“Coriobacteriaceae members were particularly found to have a strong correlation with plasma non-HDL-C and TG levels in hamsters [34, 35].”
BackgroundFarhat, Z., Sampson, J. N., Hildesheim, A., Safaeian, M., Porras, C., Cortés, B., Herrero, R., Romero, B., Vogtmann, E., Sinha, R., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0361 · Cited by 23
Sung, R., & Heo, Y. S. (2020) · Biosensors · doi:10.3390/bios11010007 · Cited by 22
Elhag, D. A., Kumar, M., & Khodor, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010125 · Cited by 27
Vaccarin enhances intestinal barrier function in type 2 diabetic mice
Sun, J., Yu, X., Hou, B., Ai, M., Qi, M., Ma, X., Cai, M.-J., Gao, M., Cai, W.-W., Ni, L., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174375 · Cited by 23
Yang, F., Zhu, W., Edirisuriya, P., Ai, Q., Nie, K., Ji, X., Li, Y., & Zhou, K. (2021) · Nutrition · doi:10.1016/j.nut.2021.111439 · Cited by 22
Cheng, T., Li, J., Chen, J., Chen, P., Ma, L.-R., Zhang, G., & Yan, P. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00516-0 · Cited by 23
“3) SCFAs are organic fatty acids with carbon atom numbers less than 6, mainly acetic acid, propionate, and butyrate [42], produced by digestion of resistant starch and dietary fibre in the intestine by different bacteria (Table 1).”
BackgroundGou, W., Miao, Z., Deng, K., & Zheng, J. (2023) · Protein & Cell · doi:10.1093/procel/pwad023 · Cited by 24
Ahmad, S., Ali, S., Rehman, A. U., Haq, I. U., Liaqat, I., Aftab, M. N., & Shume, T. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002117 · Cited by 22
“In addition to systemic inflammation, SCFAs have been studied for their potential association with obesity [73–75].”
Yue, F., Lin, X., Wu, S., Lin, W., Zhou, Z., Shi, Y., Lam, S. M., Shui, G., Xiang, X., Russell, R., et al. (2022) · Obesity · doi:10.1002/oby.23380 · Cited by 22
“Study findings are conflicting as to whether SCFAs are beneficial or detrimental to obesity and metabolic health (37,38).”
BackgroundMortaş, H., Bilici, S., Öztürk, H., & Karakan, T. (2022) · Chronobiology International · doi:10.1080/07420528.2022.2044349 · Cited by 22
“…studies, obese individuals have been shown to have a higher concentration of fecal SCFAs (RahatRozenbloom et al. 2014; Schwiertz et al. 2010). de la Cuesta-Zuluaga et al. (2019), in which 441 adults carried out gut microbiota and SCFAs analyzed in fecal samples, fecal SCFAs concentration was…”
BackgroundResultDou, P., Li, X., Zou, X., Wang, K., Yao, L., Sun, Z., Hong, H., Luo, Y., & Tan, Y. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250164 · Cited by 23
Chang, X., Shen, Y., Yang, M., Yun, L., Liu, Z., Feng, S., Yang, G., Meng, X., & Su, X. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134444 · Cited by 21
Wang, Y., Wang, H., Howard, A. G., Tsilimigras, M. C. B., Avery, C. L., Meyer, K. A., Sha, W., Sun, S., Zhang, J., Su, C., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa263 · Cited by 22
“However, human observational studies suggest that higher concentrations of fecal and plasma SCFAs are associated with poorer gut health and higher obesity and hypertension risk (50, 51).”
BackgroundCui, M., Trimigno, A., Castro-Mejía, J. L., Reitelseder, S., Bülow, J., Bechshøft, R. L., Nielsen, D. S., Holm, L., Engelsen, S. B., & Khakimov, B. (2021) · Metabolites · doi:10.3390/metabo11110717 · Cited by 25
“found a close relationship between gut microbiome dysbiosis, obesity, CVD risk factors, and fecal short-chain fatty acids (SCFAs) levels in community-dwelling adults [25].”
BackgroundMcMahan, R. H., Hulsebus, H. J., Najarro, K. M., Giesy, L. E., Frank, D. N., & Kovacs, E. J. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.08.011 · Cited by 21
Association between diet and fecal microbiota along the first year of life
Gómez‐Martín, M., Saturio, S., Arboleya, S., Herrero-Morín, D., Calzón, M., López, T., González, S., & Gueimonde, M. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111994 · Cited by 22
Ko, J., Yoo, C., Xing, D., Chun, J., Gonzalez, D. E., Dickerson, B. L., Leonard, M., Jenkins, V. M., van der Merwe, M., Slupsky, C. M., et al. (2024) · Nutrients · doi:10.3390/nu16193387 · Cited by 20
Zhang, G., Ren, Q., Ma, S., Wu, J., Yang, X., & Yu, Y. (2020) · Environment International · doi:10.1016/j.envint.2020.105770 · Cited by 20
Matysik, S., Krautbauer, S., Liebisch, G., Schött, H.-F., Kjølbæk, L., Astrup, A. V., Blachier, F., Beaumont, M., Nieuwdorp, M., Hartstra, A. V., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15440 · Cited by 20
“Some reports recorded positive associations of SCFAs and BMI including a recently published metaanalysis of seven different studies (de la Cuesta-Zuluaga et al., 2018; Kim et al., 2019; McOrist et al., 2011).”
ResultPan, X., Chen, S., Chen, X., Ren, Q., Yue, L., Niu, S., Li, Z., Zhu, R., Chen, X., Jia, Z., et al. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2923291 · Cited by 19
“Previous studies showed that obesity causes alterations in cardiac energy metabolism in cardiomyocytes, particularly fatty acid metabolism [9, 10], and analysis has revealed that acyl-CoA synthetase long-chain family member 1 (ACSL-1) and glucose transporter member 4 (GLUT-4) may be the key proteins responsible for he…”
BackgroundCaffeine-Induced Sleep Restriction Alters the Gut Microbiome and Fecal Metabolic Profiles in Mice
Song, Z., Liu, L., Xu, Y., Cao, R., Lan, X., Pan, C., Zhang, S., & Zhao, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314837 · Cited by 19
“The excretion of higher short-chain fatty acids (SCFAs) has been associated with health problems such as dysbiosis, excess adiposity, and cardiometabolic diseases [67].”
BackgroundOrtiz, J. A., Lorente-Ros, Á., Briones-Figueroa, A., Morán‐Álvarez, P., Fernández, A. G., Garrote-Corral, S., Amil-Casas, I., Carrasco-Sayalero, Á., Velarde, A. T., Camino-López, A., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20854 · Cited by 20
“SCFAs are an exclusive bacterial metabolite normally derived from complex carbohydrate fermentation that has classically been measured in fecal samples [40].”
BackgroundGut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 21
Importance of “muscle” and “intestine” training before major HPB surgery: A review
Yokoyama, Y., Nagino, M., & Ebata, T. (2020) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.835 · Cited by 19
Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes
Ward, N. C., Carnagarin, R., Nolde, J. M., Lugo‐Gavidia, L. M., Chan, J., Jose, A., Robinson, S., Joyson, A., & Schlaich, M. P. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003190 · Cited by 18
Ostrowska, J., Samborowska, E., Jaworski, M., Toczyłowska, K., & Szostak-Węgierek, D. E. (2024) · Nutrients · doi:10.3390/nu16020266 · Cited by 23
“Moreover, several studies have indicated that elevated concentrations of SCFAs in stool samples are linked to adverse health outcomes such as gut microbiome dysbiosis, obesity, hypertension, and other risk factors for cardiometabolic diseases [10].”
BackgroundNechalová, L., Bielik, V., Hric, I., Babicová, M., Baranovičová, E., Grendár, M., Koška, J., & Penesová, A. (2024) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-024-01029-7 · Cited by 19
“Several studies have established a link between changes in the relative abundance of SCFA-producing bacteria and obesity [8, 71, 72].”
Imbalance in the force: the dark side of the microbiota on stroke risk and progression
Kumar, K. P., & Wong, C. H. Y. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.10.002 · Cited by 19
Zhang, Q., Meng, N., Liu, Y., Zhao, H., Zhao, Z., Hao, D., Li, R., Kunchen, H. A. N., Li, H., Ma, J., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1070223 · Cited by 20
“Higher levels of fecal SCFAs are associated with gut dysbiosis, obesity, and hypertension, presumably due to the lower absorption rate of SCFAs in the gut (47).”
Backgrounddos Santos, A., & Vasylyshyn, A. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1595057 · Cited by 19
Goya‐Jorge, E., Gonza, I., Bondue, P., Douny, C., Taminiau, B., Daube, G., Scippo, M., & Delcenserie, V. (2022) · Foods · doi:10.3390/foods11131946 · Cited by 17
IGUDESMAN, D. A., Crandell, J., Corbin, K. D., Muntis, F. R., Zaharieva, D. P., Casu, A., Thomas, J. M., Bulik, C. M., Carroll, I. M., Pence, B. W., et al. (2022) · Current Developments in Nutrition · doi:10.1093/cdn/nzac107 · Cited by 17
Ban, Q., Chi, W., Tan, Y., Wang, S., Li, N., Song, L., Huang, X., Wang, D., Peng, W., Granato, D., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3237 · Cited by 18
The Interplay of Microbiome Dysbiosis and Cardiovascular Disease
Zaher, A., ElSaygh, J., Peterson, S. J., Weisberg, I. S., Parikh, M. A., & Frishman, W. H. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000701 · Cited by 19
“56 Additionally, the Mediterranean diet, known to elevate SCFA levels, has been reported to exhibit a blood pressure-lowering effect.”
Zhuo, L., Yang, Y., Xiao, C., Li, F., Lin, L., Xi, Y., Fu, Y., Zheng, J., & Chen, Y. (2024) · Food & Function · doi:10.1039/d4fo00961d · Cited by 17
Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes
Ismail, H. M., Perera, D. N., Mandal, R. K., DiMeglio, L. A., Evans‐Molina, C., Hannon, T. S., Petrosino, J. F., Cregeen, S. J., & Schmidt, N. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae529 · Cited by 19
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity
Amin, U., Huang, D. C., Dhir, A., Shindler, A. E., Franks, A. E., & Thomas, C. J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2427312 · Cited by 17
Complementary Feeding and Infant Gut Microbiota: A Narrative Review
Noles, D. L., Matzeller, K. L., Frank, D. N., Krebs, N. F., & Tang, M. (2025) · Nutrients · doi:10.3390/nu17050743 · Cited by 19
“In this review, butyric acid concentration increased with solid food introduction; while in adults, some studies found a higher fecal butyrate concentration was associated with worse metabolic outcomes [61], this relationship has not been well studied in infants [47].”
Huart, J., Cirillo, A., Taminiau, B., Descy, J., Saint‐Remy, A., Daube, G., Krzesinski, J.-M., Melin, P., Tullio, P. D., & Jouret, F. (2021) · Metabolites · doi:10.3390/metabo11050282 · Cited by 24
“In stools of HT patients, higher levels of SCFAs have been previously measured by gas or liquid chromatography/mass spectrometry [17,28] as well as by 1H-NMR [25].”
MethodYamamura, R., Nakamura, K., Ukawa, S., Okada, E., Nakagawa, T., Imae, A., Kunihiro, T., Kimura, T., Hirata, T., & Tamakoshi, A. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.06.003 · Cited by 17
“Although animal experiments and in vitro studies have shown that 30 these SCFAs contribute to improved glucose homeostasis and insulin sensitivity [8], several 31 epidemiological studies have found that fecal concentrations of each subtype of SCFAs and total 32 SCFAs are positively correlated with the prevalence of ob…”
BackgroundMethodResultInfluentialStereoselective metabolic disruption of cypermethrin by remolding gut homeostasis in rat
Zhang, Q., Gu, S., Wang, Y., Hu, S., Yue, S., & Wang, C. (2022) · Journal of Environmental Sciences · doi:10.1016/j.jes.2022.03.035 · Cited by 17
The Gut Microbiota: a Novel Player in the Pathogenesis of Uterine Fibroids
Vineetha, K. K., Bhat, R. G., Rao, B. K., & Archana, P. R. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01289-7 · Cited by 20
“An imbalance in the gut microbiota termed gut dysbiosis may result from the translocation of colonic bacteria, an increase in small bowel bacteria, a shift in the relative ratio of beneficial to pathogenic microbes, or any combination of these factors [24, 39, 40].”
BackgroundLi, L., Zhong, S.-J., Cheng, B., Qiu, H., & Hu, Z. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/9097821 · Cited by 17
Zhang, Y., Tang, Y., Cai, L., He, J., Chen, L., Ouyang, K., & Wang, W. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/6208680 · Cited by 16
Tarantino, G., & Citro, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041993 · Cited by 16
“It is well known that higher SCFA excretion was associated with evidence of gut dysbiosis, gut permeability, and excess adiposity [71].”
BackgroundFrom Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke
Raghani, N. R., Postwala, H. I., Shah, Y. B., Chorawala, M. R., & Parekh, P. S. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10295-3 · Cited by 16
Brosolo, G., Porto, A. D., Marcante, S., Capilupi, F., Bertin, N., Vivarelli, C., Bulfone, L., Vacca, A., Catena, C., & Sechi, L. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177107 · Cited by 17
Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
Chaikijurajai, T., & Tang, W. H. W. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00503-4 · Cited by 17
Nandy, D., Craig, S. J. C., Cai, J., Tian, Y., Paul, I. M., Savage, J. S., Marini, M. E., Hohman, E. E., Reimherr, M. L., Patterson, A. D., et al. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12833 · Cited by 17
“et al.(15)) would be necessary to elucidate mechanistically the metabolome's effects on human health.”
BackgroundBrignardello, J., Fountana, S., Posma, J. M., Chambers, E. S., Nicholson, J. K., Wist, J., Frost, G. S., García‐Pérez, I., & Holmes, E. C. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab211 · Cited by 18
Łoniewski, I., Szulińska, M., Kaczmarczyk, M., Podsiadło, K., Styburski, D., Skonieczna‐Żydecka, K., & Bogdański, P. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03801-0 · Cited by 18
“[29] observed the association between SCFA excretion and gut dysbiosis, increased gut permeability, adiposity, and cardiometabolic risk factors.”
BackgroundOrtega-Vega, E. L., Guzmán-Castañeda, S. J., Campo, O., Velásquez-Mejía, E. P., de la Cuesta‐Zuluaga, J., Bedoya, G., & Escobar, J. S. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1619440 · Cited by 19
Self-citationZhao, L., Xu, J. Z., Li, X., Liu, S., Du, J., Jia, X., Wang, Z., Ge, L., Cui, K., Ga, Y., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109679 · Cited by 15
Wang, S., Wen, Q., Qin, Y., Xia, Q., Shen, C., & Song, S. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00540-5 · Cited by 16
“Dysbiosis in gut microbiota due to antibiotic treatment led to an increase of gut mucosal permeability [30, 31], which may augment systemic exposure to xenobiotics.”
BackgroundAntihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension
Lucas, S. E., Walton, S. L., Colafella, K. M. M., Mileto, S. J., Lyras, D., & Denton, K. M. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20073 · Cited by 18
Muradi, A., Jasirwan, C. O. M., Simanjuntak, C. D. T., Pratama, D., Suhartono, R., Darwis, P., & Kekalih, A. (2022) · Life · doi:10.3390/life12101464 · Cited by 17
Guimarães, V. H. D., Marinho, B. M., Motta‐Santos, D., Mendes, G. D. R. L., & Santos, S. H. S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109252 · Cited by 15
Reyes, R. E., Gao, L., Zhang, Z., Davies, D. L., & Asatryan, L. (2022) · Alcohol · doi:10.1016/j.alcohol.2021.12.003 · Cited by 15
Smith, M. M., Polite, L. N., Christy, A., Edirisinghe, I., Burton‐Freeman, B. M., & Sandhu, A. K. (2023) · Metabolites · doi:10.3390/metabo13111106 · Cited by 14
“De la Cuesta-Zuluaga et al. also reported positive associations between obesity, central obesity and hypertension and SCFA content [23].”
BackgroundThe impacts of obesity in rheumatoid arthritis and insights into therapeutic purinergic modulation
Braga, G. D. C., Simões, J. L. B., dos Santos, Y. J. T., Filho, J. C. M., & Bagatini, M. D. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112357 · Cited by 16
Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
Maher, S., Rajapakse, J., El-Omar, E. M., & Zekry, A. (2024) · Seminars in Liver Disease · doi:10.1055/a-2438-4383 · Cited by 16
“72 77 Patients with MASLD have also been shown to have elevated fecal and serum SCFA levels, as well as upregulated expression of genes associatedwith SCFA synthesis compared with non-MASLD controls.”
Jung, D. H., Yong, J. H., Hwang, W., Yoon, M. Y., & Yoon, S. S. (2021) · Journal of Biological Engineering · doi:10.1186/s13036-021-00259-4 · Cited by 14
do Nascimento, R. D. P., Polezi, G., Rizzato, J. S., Batista, P. B., dos Santos, N. M., Filho, P. S. L., Reguengo, L. M., Morari, J., Bogusz, S., PAIOTTI, A. P. R., et al. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101447 · Cited by 14
Tuplin, E. W. N., Alukic, E., Lowry, D. E., Chleilat, F., Wang, W., Cho, N. A., Sampsell, K., Sales, K. M., Mayengbam, S., McCoy, K. D., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101750r · Cited by 17
Wu, S., Ren, L., Li, J., Shen, X. P., Zhou, Q., Miao, Z., Jia, W., He, F., & Cheng, R. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-03020-9 · Cited by 20
Mazzoli, A., Porzio, A. D., Gatto, C., Crescenzo, R., Nazzaro, M., Spagnuolo, M. S., Baccigalupi, L., Ricca, E., Amoresano, A., Fontanarosa, C., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109247 · Cited by 14
Rodrigues, V. S. T., de Moura, E. G., Peixoto, T. C., Soares, P. N., Lopes, B. P., Bertasso, I. M., Silva, B. S. D., Cabral, S. S., Kluck, G. E. G., Atella, G. C., et al. (2022) · Physiological Reports · doi:10.14814/phy2.15191 · Cited by 14
Tews, H. C., Elger, T., Gunawan, S., Fererberger, T., Sommersberger, S., Loibl, J., Huss, M., Liebisch, G., Müller, M., Kandulski, A., et al. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01929-6 · Cited by 14
“Elevated SCFA levels were related to gut microbiome dysbiosis, increased gut permeability and higher levels of high-sensitive CRP levels in blood [53].”
BackgroundNayman, E. I., Schwartz, B. A., Polmann, M. B., Gumabong, A. C., Nieuwdorp, M., Cickovski, T., & Mathee, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-54769-4 · Cited by 13
Short-Chain Fatty Acids and Preeclampsia: A Scoping Review
Zhao, H. J., Chen, Y., Liu, T., McArthur, K., & Mueller, N. T. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae057 · Cited by 13
Self-citationRibeiro, G., Schellekens, H., Cuesta‐Marti, C., Maneschy, I. R., Ismael, S., Cuevas‐Sierra, A., Martínez, J. A., Silvestre, M. P., Marques, C., Moreira-Rosário, A., et al. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00227.2024 · Cited by 14
Paniagua, G., Couce-Sánchez, M., González-Blanco, L., Sabater, C., García-Fernández, A., Rodríguez-Revuelta, J., Sáiz, P. A., Bobes, J., Margollés, A., & García‐Portilla, M. P. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111345 · Cited by 16
Barbosa, J. C., Machado, D., Almeida, D., Andrade, J. C., Brandelli, A., Gomes, A., & Freitas, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85170-1.00012-9 · Cited by 21
Yang, T., Wu, C., Li, Y., Wang, C., Mao, Z., Huo, W. Q., Yan, L., Li, Y., Xing, W., & Li, L. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.03.014 · Cited by 14
Cao, X., Zolnikova, O. Y., Maslennikov, R. V., Reshetova, M. S., Poluektova, E. A., Bogacheva, A., Жаркова, М. С., & Ivashkin, V. T. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5040038 · Cited by 12
“It has been reported that higher levels of SCFAs in feces are associated with a low diversity of microbiota, high intestinal permeability, and changes in the Firmicutes/Bacteroidetes ratio [13,24–26].”
BackgroundResultLammi, C., Ottaviano, E., Fiore, G., Bollati, C., d’Adduzio, L., Fanzaga, M., Ceccarani, C., Vizzuso, S., Zuccotti, G., Borghi, E., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02444-w · Cited by 13
Palmas, V., Deledda, A., Heidrich, V., Sanna, G., Cambarau, G., Fosci, M., Puglia, L., Cappai, E. A., Lai, A., Loviselli, A., et al. (2025) · Metabolites · doi:10.3390/metabo15010022 · Cited by 14
“…beneficial bacteria, they have been associated with metabolic diseases in both human and animal studies as well as with obesity, and, at the same time, an increased production of SCFAs and metabolites produced by members of this family has been associated with gut dysbiosis and obesity [154–157].”
Fecal Short-Chain Fatty Acids (SCFAs) and Their Role in Metabolic Disorders: A Systematic Review
Ahmad, S., Assaf, M., Thomas, B., Ibrahim, H. M., Muppuri, G., Chand, P., Mercy, A., Kumar, M., Kumar, R., & Khan, A. S. (2025) · Cureus · doi:10.7759/cureus.91579 · Cited by 30
The Influence of Diet and Sex on the Gut Microbiota of Lean and Obese JCR:LA-cp Rats
Resch, C. T., Parikh, M., Austria, J. A., Proctor, S. D., Netticadan, T., Blewett, H., & Pierce, G. N. (2021) · Microorganisms · doi:10.3390/microorganisms9051037 · Cited by 13
Qi, Y., Jiang, Y.-H., Jiang, L., Shao, L.-L., Yang, X., & Yang, C.-H. (2021) · Dose-Response · doi:10.1177/15593258211011342 · Cited by 12
Shin, W., Hackley, L. A., & Kim, H. J. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1626684 · Cited by 12
“An altered microbial population, due to the compromised anoxic microenvironment, substantially leads to the compromised short-chain fatty acid (SCFA) production.(23) All of these perturbations of barrier function were proven to lead to inflammation of the intestinal tract.”
BackgroundGonzález-Soltero, R., Tabone, M., Larrosa, M., Bailén, M., & Bressa, C. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1423472 · Cited by 12
Sayol-Altarriba, A., Aira, A., Villasante, A., Albarracín, R., Faneca, J., Casals, G., Villanueva‐Cañas, J. L., & Casals‐Pascual, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2415488 · Cited by 14
Zhou, J., Zhang, H., Huo, P., Shen, H., Huang, Q. E., Yang, L., Liu, A., Chen, G., Tao, F., Liu, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78463-7 · Cited by 17
Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health
Guerrero, I. A. C., Martínez-Medina, A. E., Alvarado-Mata, L. Y., Chávez, A. C. F., Muñoz-García, R., Luévanos‐Escareño, M. P., Sosa-Martínez, J. D., Castro-Alonso, M. J., Nimmakayala, P., Reddy, U. K., et al. (2025) · Metabolites · doi:10.3390/metabo15060372 · Cited by 12
“…presence of microbial strains that are associated with these diseases: Enterobacter hormaechei , Haemophilus parainfluenzae , Streptococcus , and SMB53 , in contrast to those individuals who show a lower level of short-chain fatty acids, show a diverse microbiome and with beneficial strains [66].”
Gut microbiota-derived SCFAs and MetS-related nephropathy
Tian, X., Sun, L., Guo, S., Yuan, L., Zhang, T., Huang, C., He, T., Jiang, Q., & Zeng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561271 · Cited by 12
Rodrigues, V. S. T., de Moura, E. G., Peixoto, T. C., Soares, P. N., Lopes, B. P., Oliveira, E., Manhães, A. C., Atella, G. C., Kluck, G. E. G., Cabral, S. S., et al. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112656 · Cited by 11
Bridgman, S. L., Malmuthuge, N., Mandal, R., Field, C. J., Haqq, A. M., Mandhane, P. J., Moraes, T. J., Turvey, S. E., Simons, E., Subbarao, P., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01183-3 · Cited by 12
Wells, R. K., Kunihiro, B. P., Phankitnirundorn, K., Peres, R., McCracken, T., Umeda, L., Lee, R. H., Kim, D. Y., Juárez, R., & Maunakea, A. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1035641 · Cited by 13
“…have reported a negative relationship between the relative abundance of butyrate-producing bacteria and T2DM risk (Arora and Tremaroli, 2021), dynamic interactions among gut bacterial butyrate metabolism and cardiometabolic health outcomes in NHPIs is unclear (De la Cuesta-Zuluaga et al., 2019).”
BackgroundDong, M., Liang, X., Zhu, T., Xu, T., Xie, L., & Feng, Y. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s454297 · Cited by 12
Wang, S., Qin, Y., Wen, Q., Xia, Q., Gu, R., Wang, S., Chen, G., Tan, C., Shen, C., & Song, S. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100458 · Cited by 16
Minaya, D. M., Kim, J. S., Kirkland, R. A., Allen, J. T., Cullinan, S., Maclang, N., de Lartigue, G., & Serre, C. B. D. L. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2421581 · Cited by 12
Zhao, J., Guo, J., Xu, X., Song, X., Kong, W., Liu, M., Zhang, T., Zeng, X., Wu, Z. F., Tao, M., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106321 · Cited by 10
Metabolic Fluctuations in the Human Stool Obtained from Blastocystis Carriers and Non-Carriers
Betts, E. L., Newton, J. M., Thompson, G. S., Sarzhanov, F., Jinatham, V., Kim, M., Popluechai, S., Al, F. D., Won, E. J., Gentekaki, E., et al. (2021) · Metabolites · doi:10.3390/metabo11120883 · Cited by 10
“In general, low amounts of SCFAs in the stool suggest their binding by gut receptors and use by enterocytes indicating a state of eubiosis [54].”
BackgroundParascinet, O., Mas, S., Hang, T., Llavero, C., Lorenzo, Ó., & Ruíz-Tóvar, J. (2023) · Nutrients · doi:10.3390/nu15051067 · Cited by 10
“muciniphila and Bacteroides, and increased blood pressure, proinflammatory markers, and the lipid/glycemic profiles [21].”
BackgroundŁoniewski, I., Szulińska, M., Kaczmarczyk, M., Podsiadło, K., Styburski, D., Skonieczna‐Żydecka, K., & Bogdański, P. (2023) · Nutrition · doi:10.1016/j.nut.2023.112109 · Cited by 10
Dai, Y., Shen, Z., Khachatryan, L., Vadiyan, D. E., Karampoor, S., & Mirzaei, R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154740 · Cited by 11
Metadata
- Authors
- De la Cuesta-Zuluaga, J., Mueller, N., Álvarez-Quintero, R., Velásquez-Mejía, E., Sierra, J., Corrales-Agudelo, V., Carmona, J., Abad, J., & Escobar, J.
- Affiliations
- Vidarium–Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Calle 8 sur #50-67, 050023 Medellin, Colombia
- Johns Hopkins University (US)
- Grupo de Investigación en Sustancias Bioactivas, Sede de Investigación Universitaria (SIU), Universidad de Antioquia, Calle 62 #52-59, 050010 Medellin, Colombia
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica IPS, Especialista en Ayudas Diagnósticas, Calle 27 #45-109, 050021 Medellin, Colombia
- EPS SURA, Calle 49A #63-55, 050034 Medellin, Colombia
- Corresponding author
- Escobar, Juan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-12-27
- Volume
- 11
- Issue
- 1
- Pages
- 51
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6356834
- OpenAlex
- W2908425894
- Semantic Scholar
- 5eb68bb6bfbbdde0888adeae7373bb6a65842f51
- Cited by
- 533
- References
- 55
- Citations by year
- 2026: 43 · 2025: 61 · 2024: 85 · 2023: 82 · 2022: 81 · 2021: 91 · 2020: 58 · 2019: 31
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (K01HL141589)
- Mid-Atlantic Nutrition Obesity Research Center (P30DK072488)
- Foundation for Gender Specific Medicine (NA)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- short-chain fatty acids, fecal SCFA, gut dysbiosis, microbiome diversity, intestinal permeability, obesity, hypertension, cardiometabolic risk factors, dietary fiber fermentation, acetate, butyrate, propionate
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Cardiovascular Diseases, Fatty Acids, Volatile, Feces, Female, Humans, Hypertension, Male, Metabolic Diseases, Middle Aged, Obesity, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.